Design and implementation of GRIP: a computerized glucose control system at a surgical intensive care unit

Mathijs Vogelzang, Felix Zijlstra, Maarten W N Nijsten, Mathijs Vogelzang, Felix Zijlstra, Maarten W N Nijsten

Abstract

Background: Tight glucose control by intensive insulin therapy has become a key part of critical care and is an important field of study in acute coronary care. A balance has to be found between frequency of measurements and the risk of hypoglycemia. Current nurse-driven protocols are paper-based and, therefore, rely on simple rules. For safety and efficiency a computer decision support system that employs complex logic may be superior to paper protocols.

Methods: We designed and implemented GRIP, a stand-alone Java computer program. Our implementation of GRIP will be released as free software. Blood glucose values measured by a point-of-care analyzer were automatically retrieved from the central laboratory database. Additional clinical information was asked from the nurse and the program subsequently advised a new insulin pump rate and glucose sampling interval.

Results: Implementation of the computer program was uneventful and successful. GRIP treated 179 patients for a total of 957 patient-days. Severe hypoglycemia (< 2.2 mmol/L) only occurred once due to human error. With a median (IQR) of 4.9 (4.2-6.2) glucose measurements per day the median percentage of time in which glucose fell in the target range was 78%. Nurses rated the program as easy to work with and as an improvement over the preceding paper protocol. They reported no increase in time spent on glucose control.

Conclusion: A computer driven protocol is a safe and effective means of glucose control at a surgical ICU. Future improvements in the recommendation algorithm may further improve safety and efficiency.

Figures

Figure 1
Figure 1
Glucose control cycle. Nurse-driven glucose control consists of the repetitive execution of the cycle depicted in this figure. First, the nurse acquires blood from the patients and gets the glucose level. A protocol or doctor then decides what action should be taken (in most cases a change of the rate of the insulin pump), and subsequently this action is performed at the bedside by the nurse.
Figure 2
Figure 2
High-level overview of GRIP. Grip contains four major components: a component to interface with the hospital information system, a component to interface with the nurse, a component that calculates the advice that GRIP gives, and a component that logs errors and stores all data GRIP generates. HL7 : Health Level 7. SQL : Standard Query Language.
Figure 3
Figure 3
Main screen of GRIP. The main screen of GRIP. An overview of the ICU is shown replicating the arrangements of beds on the floor. Beds have colors according to pending action: green – no action has to be taken, orange – action has to be taken and a small icon indicates what action, in this case a new glucose value was detected in the hospital data system, which needs a validation from the nurse, and red – urgent action required, for example occurrence of hypoglycemia, or an advised measurement that is more than 30 minutes late. Each bed shows the current insulin pump rate, the most recent glucose value and the time it was taken, and the time the next glucose value needs to be taken. Empty beds are shown in grey. Each bed is clickable to yield a more detailed information panel shown in figure 4.
Figure 4
Figure 4
Patient overview in GRIP. The patient overview panel shows more detailed information for a single patient. On the left general characteristics such as patient ID number, birth-date and sex are shown. The middle three panels show the current status, the recommendation of GRIP, and the tasks GRIP thinks the user should perform.
Figure 5
Figure 5
Glucose control. Median and interquartile range of glucose levels are shown for the 109 patients with a length of stay longer than 1 day. The dashed line equals the glucose target of GRIP.
Figure 6
Figure 6
Results of the nurse questionnaire. Results of the nurse questionnaires 1 month before (N = 32) and 6 months after (N = 22) implementing GRIP. Questions pertaining to GRIP were only asked in the questionnaire held after 6 months. The median and interquartile range of responses are shown for each question asked.

References

    1. Mizock BA. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab. 2001;15:533–551. doi: 10.1053/beem.2001.0168.
    1. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978–982. doi: 10.1210/jc.87.3.978.
    1. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773–778. doi: 10.1016/S0140-6736(99)08415-9.
    1. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32:2426–2432.
    1. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–1367. doi: 10.1056/NEJMoa011300.
    1. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004;79:992–1000.
    1. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM, Surviving Sepsis Campaign Management Guidelines Committee Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32:858–873. doi: 10.1097/01.CCM.0000117317.18092.E4.
    1. Brown G, Dodek P. Intravenous insulin nomogram improves blood glucose control in the critically ill. Crit Care Med. 2001;29:1714–1719. doi: 10.1097/00003246-200109000-00010.
    1. Goldberg PA, Siegel MD, Sherwin RS, Halickman JI, Lee M, Bailey VA, Lee SL, Dziura JD, Inzucchi SE. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004;27:461–467.
    1. Chant C, Wilson G, Friedrich JO. Validation of an insulin infusion nomogram for intensive glucose control in critically ill patients. Pharmacotherapy. 2005;25:352–359. doi: 10.1592/phco.25.3.352.61594.
    1. van der Horst IC, Zijlstra F, van't Hof AW, Doggen CJ, de Boer MJ, Suryapranata H, Hoorntje JC, Dambrink JH, Gans RO, Bilo HJ, Zwolle Infarct Study Group Glucose-insulin-potassium infusion in patients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial. J Am Coll Cardiol. 2003;42:784–791. doi: 10.1016/S0735-1097(03)00830-1.
    1. Mehta SR, Yusuf S, Díaz R, Zhu J, Pais P, Xavier D, Paolasso E, Ahmed R, Xie C, Kazmi K, Tai J, Orlandini A, Pogue J, Liu L, CREATE-ECLA Trial Group Investigators Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA. 2005;293:437–446. doi: 10.1001/jama.293.14.1746.
    1. Malmberg K, Rydén L, Efendic S, Herlitz J, Nicol P, Waldenström A, Wedel H, Welin L. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57–65. doi: 10.1016/0735-1097(95)00126-K.
    1. Malmberg K, Rydén L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt P, MacLeod K, Laakso M, Torp-Pedersen C, Waldenström A, DIGAMI 2 Investigators Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26:650–661. doi: 10.1093/eurheartj/ehi199.
    1. Kawamoto K, Houlihan CA, Balas EA, Lobach DF. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ. 2005;330:765. doi: 10.1136/bmj.38398.500764.8F.
    1. Prigeon RL, Røder ME, Porte D, Kahn SE. The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans. J Clin Invest. 1996;97:501–507.
    1. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA. 2003;290:2041–2047. doi: 10.1001/jama.290.15.2041.
    1. van den Berghe G, Bouillon R. Optimal control of glycemia among critically ill patients. JAMA. 2004;291:1198–1199. doi: 10.1001/jama.291.10.1198-b.
    1. Chase JG, Shaw GM, Lin J, Doran CV, Hann C, Lotz T, Wake GC, Broughton B. Targeted glycemic reduction in critical care using closed-loop control. Diabetes Technol Ther. 2005;7:274–282. doi: 10.1089/dia.2005.7.274.
    1. Free Software Foundation GNU General Public License
    1. Vogelzang M, van der Horst IC, Nijsten MW. Hyperglycaemic index as a tool to assess glucose control: a retrospective study. Crit Care. 2004;8:R122–R127. doi: 10.1186/cc2840.
    1. Chee F, Fernando TL, Savkin AV, van Heeden V. Expert PID control system for blood glucose control in critically ill patients. IEEE Trans Inf Technol Biomed. 2003;7:419–425. doi: 10.1109/TITB.2003.821326.
    1. Goldberg PA, Siegel MD, Russell RR, Sherwin RS, Halickman JI, Cooper DA, Dziura JD, Inzucchi SE. Experience with the continuous glucose monitoring system in a medical intensive care unit. Diabetes Technol Ther. 2004;6:339–347. doi: 10.1089/152091504774198034.
    1. Hann CE, Chase JG, Lin J, Lotz T, Doran CV, Shaw GM. Integral-based parameter identification for long-term dynamic verification of a glucose-insulin system model. Comput Methods Programs Biomed. 2005;77:259–270. doi: 10.1016/j.cmpb.2004.10.006.
    1. Rood E, Bosman RJ, van der Spoel JI, Taylor P, Zandstra DF. Use of a computerized guideline for glucose regulation in the intensive care unit improved both guideline adherence and glucose regulation. J Am Med Inform Assoc. 2005;12:172–180. doi: 10.1197/jamia.M1598.

Source: PubMed

3
Subscribe